(11143129), L. R., (10430738), D. C., (166886), X. Z., (22678979), S. S., (93650), R. F., (159269), X. C., . . . (159274), H. C. (2025). Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: A multicenter study.docx.
Citação norma Chicago(11143129), Liying Ren, et al. Data Sheet 1_Development and Validation of the FAAP Model for Prognostic Stratification in HCC Patients Treated with TACE, Sintilimab Plus Bevacizumab: A Multicenter Study.docx. 2025.
Citação norma MLA(11143129), Liying Ren, et al. Data Sheet 1_Development and Validation of the FAAP Model for Prognostic Stratification in HCC Patients Treated with TACE, Sintilimab Plus Bevacizumab: A Multicenter Study.docx. 2025.